Skip to content
Research Article Open access CC BY 4.0

Pattern of Dyslipidemia in Type 2 Diabetic Patients in Fayoum (Egypt)

Mohamed Masahhit, Hoda A. Husain, Reham Samir

Asian Journal of Medicine and Health · pp. 1–12 · Published 1 Nov 2017

10.9734/AJMAH/2017/36088

Abstract

Background: People with type 2 Diabetes (type II DM) have an elevated risk for developing cardiovascular disease (CVD) for which Dyslipidemia is the major contributor. Diabetic patients have characteristic pattern of dyslipidemia with Decreased level of high density lipoprotein cholesterol (HDL-C) and elevated triglycerides (TG) level, high serum VLDL-triglycerides and a preponderance of small, dense LDL. This Study Aimed: To study the pattern of dyslipidemia in Egyptian type II diabetic patients. Subject and Method: The study included 500 subjects: Four hundred type -2 diabetic  patients   of  both  sexes   aged  20 - 65  years  from different rural and urban areas of  Fayoum governorate with no past or current history of lipid lowering agents and one hundred age & sex matched individuals as a control group. A Full medical history including the patient`s age, sex, duration of diabetes, family history of diabetes, drugs used in treatment of diabetes and history of CVD. An overnight   fasting blood sample was obtained for (Total cholesterol, LDL-C, HDL-C, TGs), HbA1c, SGPT, SGOT, Creatinine and Urea, CBC. The Results: showed that 48.3% of the diabetics had hypercholesterolemia (TC  ≥ 200  mg/dL),  62.5% had hypertriglyceridemia (TG ≥ 15 0 mg/dL) 61.8% had serum LDL-C ≥ 100  mg/dL and 12.5% of diabetics had a an (HDL-C < 40 mg/dL. Conclusion: This study concluded that serum levels of total cholesterol and LDL-C are elevated, HDL levels are lowered in Egyptian diabetics compared to non-diabetics. So, we can recommend that measurement of serum lipid profile should be included in the management plan of diabetics.

Type II DM dyslipidemia and cardiovascular disease

Cited by 3

Study Role of Gender and Clinical Chemistry Data in Type 2 Diabetes Mellitus Patients

M. Fouda, A. Shokry, D. M. Hasseb · Benha Journal of Applied Sciences · 2020

Sarcopenia: a chronic complication of type 2 diabetes mellitus

H. Trierweiler, G. Kisielewicz, Thaísa Hoffmann Jonasson · Diabetology & Metabolic Syndrome · 2018

Role of dipeptidyl peptidase 4 in type 2 diabe tes mellitus

O. S. El Shaer, H. A. Issaa, A. A. El Falah · 2020

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

3

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.